Tevogen Signs Letter Of Intent To Evaluate A Potential Transaction With HRK Healthcare; Sees Path To Realizing ~$100M In Combined Annual Revenue

Tevogen Inc. (NASDAQ: TVGN) has signed a non-binding Letter of Intent to evaluate a potential transaction with HRK Healthcare LLC. If completed, this transaction could enhance Tevogen's healthcare infrastructure and support its goal of achieving approximately $100 million in combined annual revenue. The deal is contingent on due diligence, negotiation, and necessary approvals. Tevogen is also exploring additional transactions in the life sciences and healthcare sectors.